GeneOhm Sciences, Inc. Completes A $14 Million Second Closing Of Series C Financing For A Total Of $26 Million; Series C Success Adds Additional World Class Investors
10/19/2005 5:12:20 PM
SAN DIEGO--(BUSINESS WIRE)--Jan. 18, 2005--GeneOhm Sciences, a leader in molecular diagnostics, announced that the company has successfully raised $14 million in a second closing of its Series C financing, bringing the total Series C to $26 million. The first closing was completed on November 24, 2004 in conjunction with the merger of GeneOhm and Infectio Diagnostic, (I.D.I.), Inc. It was followed closely by the second closing, which was finalized on December 17, 2004.